IATDMCT 2017

Presentation information

Print

Oral

[O26-1] O26-1: Immunosuppressive drugs: assey and genotyping

Tue. Sep 26, 2017 10:30 AM - 11:15 AM Room C1 (1F)

Chairs: Stein Bergan, Norway / Maria Shipkova, Germany

[O26-1-3] Is CYP3A5*3 genotyping for tacrolimus dosing really beneficial?

Tester F. Ashavaid1, Swarup A. V. Shah2, Alan Almeida3, Jatin Kothari4, Ashok Kirpalani5 (1.P.D. Hinduja National Hospital and Medical Research Centre, 2.P.D. Hinduja National Hospital and Medical Research Centre, 3.P.D. Hinduja National Hospital and Medical Research Centre, 4.P.D. Hinduja National Hospital and Medical Research Centre, 5.Bombay Hospital & Medical Research Centre)

Keywords:CYP3A5*3 GENOTYPING, TACROLIMUS, CPIC, INDIANS, PHARMACOGENETICS

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password